Spectral AI (MDAI) Revenue & Revenue Breakdown
Spectral AI Revenue Highlights
Latest Revenue (Y)
$29.58M
Latest Revenue (Q)
$5.07M
Spectral AI Revenue by Period
Spectral AI Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $29.58M | 63.83% |
| 2023-12-31 | $18.06M | -28.82% |
| 2022-12-31 | $25.37M | 66.47% |
| 2021-12-31 | $15.24M | - |
Spectral AI generated $29.58M in revenue during NA 2024, up 63.83% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Spectral AI Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $5.07M | -24.48% |
| 2025-03-31 | $6.71M | -11.80% |
| 2024-12-31 | $7.60M | -6.96% |
| 2024-09-30 | $8.17M | 9.29% |
| 2024-06-30 | $7.48M | 18.21% |
| 2024-03-31 | $6.33M | 19.65% |
| 2023-12-31 | $5.29M | 53.69% |
| 2023-09-30 | $3.44M | -19.08% |
| 2023-06-30 | $4.25M | -16.29% |
| 2023-03-31 | $5.08M | -16.70% |
| 2022-12-31 | $6.10M | -13.38% |
| 2022-09-30 | $7.04M | 100.00% |
| 2022-06-30 | - | -100.00% |
| 2022-03-31 | $5.84M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | - |
Spectral AI generated $5.07M in revenue during Q2 2025, up -24.48% compared to the previous quarter, and up 80.07% compared to the same period a year ago.
Spectral AI Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CAMP | CAMP4 Therapeutics | $186.23M | $858.00K |
| LUNG | Pulmonx | $83.79M | $23.86M |
| TELA | TELA Bio | $69.30M | $20.20M |
| EDAP | Edap Tms | $59.18M | $15.00M |
| MDAI | Spectral AI | $29.58M | $5.07M |
| CTSO | Cytosorbents | $25.13M | $8.73M |
| ADAG | Adagene | $18.11M | $833.34K |
| ICCM | IceCure Medical | $3.23M | $736.35K |
| AEMD | Aethlon Medical | - | - |
| VANI | Vivani Medical | - | - |
| GANX | Gain Therapeutics | - | - |